Bono, J. S. D., Garmezy, B., Ye, D., Piulats, J. M., Sandhu, S., Parsonson, A. O., Weickhardt, A. J., Tewari, A., Reid, A. H., Song, B., Wei, J., Wu, P., Mu, H., Ulrich, L., Argon, E. K., OBrate, A., Pinho, M., Helian, S., Tibes, R., Stein, M. N. (2026). BNT324-03: Phase 3, randomized, open-label trial of BNT324/DB-1311, a B7H3 ADC, versus docetaxel in patients with taxane-naïve metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps5137